Clinical Evaluation of Three Sample-to-Answer Platforms for Detection of SARS-CoV-2-Reference-Cited by-同舟云学术

Clinical Evaluation of Three Sample-to-Answer Platforms for Detection of SARS-CoV-2

Published:2020-07-23 Issue:8 Volume:58 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Zhen Wei¹,Smith Elizabeth¹,Manji Ryhana¹,Schron Deborah²,Berry Gregory J.¹²

Affiliation:

1. Infectious Disease Diagnostics, Northwell Health Laboratories, Lake Success, New York, USA

2. Department of Pathology and Laboratory Medicine, The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, East Garden City, New York, USA

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now spread across the globe. As part of the worldwide response, many molecular diagnostic platforms have been granted e mergency u se a uthorization (EUA) by the Food and Drug Administration (FDA) to identify SARS-CoV-2 positive patients. Our objective was to evaluate three sample-to-answer molecular diagnostic platforms (Cepheid Xpert Xpress SARS-CoV-2 [Xpert Xpress], Abbott ID NOW COVID-19 [ID NOW], and GenMark ePlex SARS-CoV-2 Test [ePlex]) to determine analytical sensitivity, clinical performance, and workflow for the detection of SARS-CoV-2 in nasopharyngeal swabs from 108 symptomatic patients.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00783-20

Reference12 articles.

1. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

2. CDC. 2020. Locations with confirmed COVID-19 cases global map. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov. Accessed 15 April 2020.

3. Center for Systems Science and Engineering. 2020. COVID-19 dashboard by the Center for Systems Science and Engineering at Johns Hopkins University. https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6. Accessed 15 April 2020.

4. WHO-China Joint Mission on Coronavirus Disease. 2020. Report of the WHO-China Joint Mission on Coronavirus Disease. https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf. Accessed 15 April 2020.

5. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

Cited by 212 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical performance of the Abbott ID NOW 2.0 assay for SARS-CoV-2 detection in clinical samples from symptomatic patients;Diagnostic Microbiology and Infectious Disease;2024-03

2. The diagnostic accuracy of the ID NOW COVID-19 point of care test in acute hospital admissions;Journal of Clinical Virology;2024-02

3. A syndromic diagnostic assay on a macrochannel-to-digital microfluidic platform for automatic identification of multiple respiratory pathogens;Lab on a Chip;2024

4. A study to assess the impact of the cobas point-of-care RT-PCR assay (SARS-CoV-2 and Influenza A/B) on patient clinical management in the emergency department of the University of California at Davis Medical Center;Journal of Clinical Virology;2023-11

5. Lessons from the pandemic: new best practices in selecting molecular diagnostics for point-of-care testing of infectious diseases in sub-Saharan Africa;Expert Review of Molecular Diagnostics;2023-10-31